June 2020 Clinical Watch Newsletter

July 8, 2020

In this issue of Clinical Watch, we discuss nitrosamine impurities found in widely used medications and suggest prior authorization criteria for a new treatment for heavy menstrual bleeding due to uterine fibroids. Lastly, we review claims data to identify the most frequently used contraceptive formulations.

For more information about a specific topic, please contact Janelle Sheen or Karen Powell. Be sure to stay tuned for future monthly updates. For more information about our solutions, please visit conduent.com/pharmacysolutions.

Previous Article
Improving Citizen Experience in Federal Government
Improving Citizen Experience in Federal Government

Next Article
Galvanizing Constituent-Centered, Strategic Public Sector EBT Services
Galvanizing Constituent-Centered, Strategic Public Sector EBT Services